Items where authors include "Flohr, C."

Article

Gribaleva, E. orcid.org/0000-0001-5693-8194, Chan, K., Chivardi Moreno, C. et al. (60 more authors) (2025) The UK-Irish Atopic eczema Systemic TherApy Register (A*STAR): baseline characteristics of the cohort. British Journal of Dermatology. ljaf039. ISSN 0007-0963

Sach, T.H., Williams, H.C., Allen, H. et al. (23 more authors) (2024) Practicality, validity and responsiveness of using the proxy version of the CHU-9D with children aged 2 to 5 years. Value in Health, 27 (12). pp. 1771-1778. ISSN 1098-3015

Alexander, H. orcid.org/0000-0002-0241-5408, Malek, R., Prieto-Merino, D. et al. (57 more authors) (2024) A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register. British Journal of Dermatology, 191 (6). pp. 988-999. ISSN 0007-0963

Bruce, G. orcid.org/0000-0003-4713-3647, Rosala-Hallas, A., Jones, A.P. et al. (28 more authors) (2024) The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children – results from the TREAT trial. British Journal of Dermatology, 191 (5). pp. 851-852. ISSN 0007-0963

Bradshaw, L.E. orcid.org/0000-0001-8382-6040, Wyatt, L.A. orcid.org/0000-0002-9817-5356, Brown, S.J. orcid.org/0000-0002-3232-5251 et al. (22 more authors) (2024) Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT. Health Technology Assessment, 28 (29). ISSN 1366-5278

Brauer, M., Roth, G.A., Aravkin, A.Y. et al. (1792 more authors) (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2162-2203. ISSN 0140-6736

Flohr, C., Cork, M.J. orcid.org/0000-0003-4428-2428, Ardern-Jones, M.R. et al. (6 more authors) (2023) Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial. Journal of Dermatological Treatment, 34 (1). 2200866. ISSN 0954-6634

Flohr, C. orcid.org/0000-0003-4884-6286, Rosala-Hallas, A., Jones, A.P. et al. (76 more authors) (2023) Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. British Journal of Dermatology, 189 (6). pp. 674-684. ISSN 0007-0963

Sach, T.H. orcid.org/0000-0002-8098-9220, Lartey, S.T., Davies, C. et al. (20 more authors) (2023) Emollients for preventing atopic eczema: cost‐effectiveness analysis of the BEEP trial. Clinical & Experimental Allergy, 53 (10). pp. 1011-1019. ISSN 0954-7894

Zuberbier, T. orcid.org/0000-0002-1466-8875, Abdul Latiff, A., Aggelidis, X. orcid.org/0000-0003-1715-3022 et al. (105 more authors) (2023) A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative. Clinical and Translational Allergy, 13 (9). e12299. ISSN 2045-7022

Flohr, C. orcid.org/0000-0003-4884-6286, Irvine, A.D. orcid.org/0000-0002-9048-2044, Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (6 more authors) (2023) Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis. British Journal of Dermatology, 189 (2). pp. 238-240. ISSN 0007-0963

Bradshaw, L.E., Wyatt, L.A., Brown, S.J. et al. (22 more authors) (2023) Emollients for prevention of atopic dermatitis; 5‐year findings from the BEEP randomised trial. Allergy, 78 (4). pp. 995-1006. ISSN 1398-9995

Jabbar‐Lopez, Z.K., Ezzamouri, B., Briley, A. et al. (11 more authors) (2022) Randomized controlled pilot trial with ion‐exchange water softeners to prevent eczema (SOFTER trial). Clinical & Experimental Allergy, 52 (3). pp. 405-415. ISSN 0954-7894

Ring, J., Worm, M., Wollenberg, A. et al. (35 more authors) (2021) Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35 (6). e362-e365. ISSN 0926-9959

Thyssen, J.P., Vestergaard, C., Barbarot, S. et al. (32 more authors) (2021) European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics. Journal of the European Academy of Dermatology and Venereology, 35 (5). e308-e311. ISSN 0926-9959

Simpson, E.L., Sinclair, R., Forman, S. et al. (14 more authors) (2020) Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet, 396 (10246). pp. 255-266. ISSN 0140-6736

Wollenberg, A., Flohr, C., Simon, D. et al. (30 more authors) (2020) European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 34 (6). e241-e242. ISSN 0926-9959

Jabbar-Lopez, Z.K., Gurung, N., Greenblatt, D. et al. (12 more authors) (2019) Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study : the softened water for eczema prevention (SOFTER) trial. BMJ Open, 9 (8).

Tziotzios, C., Petridis, C., Dand, N. et al. (71 more authors) (2019) Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02. Nature Communications, 10. 1150. ISSN 2041-1723

Simpson, E.L., Reynolds, N.J., Flohr, C. et al. (5 more authors) (2018) Response to "Comment on: 'When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council'''. Journal of The American Academy of Dermatology, 79 (2). E25-E26. ISSN 0190-9622

Danby, S.G. orcid.org/0000-0001-7363-140X, Brown, K., Wigley, A. et al. (4 more authors) (2018) The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects. Journal of Investigative Dermatology, 138 (1). pp. 68-77. ISSN 0022-202X

Simpson, E.L., Bruin-Weller, M., Flohr, C. et al. (26 more authors) (2017) When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. Journal of The American Academy of Dermatology, 77 (4). pp. 623-633. ISSN 0190-9622